Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 3 Anxiety “Hamilton Anxiety Rating Scale” in RA patients during COVID-19 outbreak

From: Hydroxychloroquine non-availability during COVID-19 pandemic and its relation to anxiety level and disease activity in rheumatoid arthritis and lupus patients: a cross-sectional study

 

With HCQ shortage (174)

Without HCQ shortage (42)

P value

Anxiety level

24.31 ± 9.6

19.73 ± 7.45

0.0044*

Mild

33 (18.9%)

16 (38.1%)

0.031*

Mild to moderate

58 (33.3%)

13 (31%)

Moderate to severe

56 (32.3%)

11 (26.2%)

Severe

27 (15.5%)

2 (4.7%)

  1. HCQ hydroxychloroquine
  2. *Significant P value if p < 0.05
Back to article page